Carman Man Chung Li, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammary Glands, Animal | 2 | 2022 | 277 | 0.720 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 67 | 0.530 |
Why?
|
| Stromal Cells | 1 | 2020 | 1353 | 0.510 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2013 | 315 | 0.400 |
Why?
|
| Epithelial Cells | 2 | 2021 | 3678 | 0.350 |
Why?
|
| Neoplasm Metastasis | 3 | 2017 | 4839 | 0.320 |
Why?
|
| Adenocarcinoma | 4 | 2017 | 6347 | 0.310 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 2417 | 0.270 |
Why?
|
| Phosphoproteins | 1 | 2013 | 2440 | 0.240 |
Why?
|
| Lung Neoplasms | 4 | 2017 | 13019 | 0.230 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2017 | 8425 | 0.210 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 12071 | 0.210 |
Why?
|
| Aging | 1 | 2020 | 8626 | 0.200 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 5851 | 0.180 |
Why?
|
| Gene Knockdown Techniques | 2 | 2015 | 1655 | 0.170 |
Why?
|
| Mammary Glands, Human | 1 | 2020 | 200 | 0.160 |
Why?
|
| Mice, Nude | 2 | 2015 | 3689 | 0.150 |
Why?
|
| Tenascin | 1 | 2017 | 59 | 0.150 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2020 | 1097 | 0.140 |
Why?
|
| Breast | 2 | 2022 | 1958 | 0.140 |
Why?
|
| Single-Cell Analysis | 3 | 2020 | 2183 | 0.130 |
Why?
|
| Transcription Factors | 1 | 2015 | 12164 | 0.130 |
Why?
|
| Cell Communication | 1 | 2021 | 1619 | 0.120 |
Why?
|
| Organoids | 1 | 2020 | 692 | 0.120 |
Why?
|
| Microfluidics | 1 | 2019 | 662 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2016 | 704 | 0.110 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2013 | 70 | 0.110 |
Why?
|
| Lymphocytes | 1 | 2020 | 2614 | 0.110 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 1670 | 0.110 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2019 | 828 | 0.100 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2019 | 933 | 0.100 |
Why?
|
| Cell Lineage | 1 | 2020 | 2504 | 0.100 |
Why?
|
| Animals, Genetically Modified | 1 | 2015 | 1546 | 0.090 |
Why?
|
| Stem Cells | 2 | 2021 | 3563 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 16665 | 0.090 |
Why?
|
| Dendritic Cells | 1 | 2020 | 2723 | 0.090 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1683 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2015 | 1538 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2013 | 1727 | 0.080 |
Why?
|
| Proteomics | 2 | 2022 | 3618 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 3585 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2019 | 5975 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2021 | 11470 | 0.070 |
Why?
|
| Macrophages | 1 | 2020 | 5655 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2016 | 2948 | 0.070 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2016 | 1631 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 21821 | 0.060 |
Why?
|
| Animals | 7 | 2022 | 168561 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 3612 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2020 | 19223 | 0.060 |
Why?
|
| Mice | 5 | 2019 | 81045 | 0.050 |
Why?
|
| Extracellular Matrix | 2 | 2021 | 1740 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2013 | 10248 | 0.050 |
Why?
|
| Biomedical Engineering | 1 | 2021 | 295 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 5249 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 20774 | 0.040 |
Why?
|
| Annexin A2 | 1 | 2017 | 44 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 2020 | 709 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 697 | 0.040 |
Why?
|
| S100 Proteins | 1 | 2017 | 259 | 0.040 |
Why?
|
| BRCA1 Protein | 1 | 2020 | 1145 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2021 | 1731 | 0.030 |
Why?
|
| Regeneration | 1 | 2021 | 1485 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2020 | 2006 | 0.030 |
Why?
|
| Disease Progression | 2 | 2017 | 13256 | 0.020 |
Why?
|
| Neoplasms | 1 | 2019 | 21596 | 0.020 |
Why?
|
| Female | 4 | 2022 | 379592 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 6313 | 0.020 |
Why?
|
| Humans | 6 | 2022 | 742088 | 0.020 |
Why?
|
| Cell Line | 1 | 2021 | 15994 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 3564 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 9735 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 12242 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 9410 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10472 | 0.010 |
Why?
|
| Pregnancy | 1 | 2022 | 29087 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 18006 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2021 | 23387 | 0.010 |
Why?
|
| Prognosis | 1 | 2017 | 29010 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 56350 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 62966 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 213127 | 0.000 |
Why?
|
| Adult | 1 | 2020 | 213712 | 0.000 |
Why?
|
| Male | 1 | 2017 | 349538 | 0.000 |
Why?
|